VEA
GOSS icon

Virtus ETF Advisers’s Gossamer Bio GOSS Stock Holding History

Virtus ETF Advisers’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-219
Closed -$210K – 463
2022
Q3 		$210K Buy
219
+2
+0.9% +$1.99K 0.08% 315
2022
Q2 		$145K Buy
217
+29
+15% +$18K 0.05% 323
2022
Q1 		$131K Sell
188
-11
-6% -$8.49K 0.06% 248
2021
Q4 		$180K Sell
199
-102
-34% -$96.9K 0.07% 247
2021
Q3 		$303K Sell
301
-16
-5% -$11.8K 0.13% 199
2021
Q2 		$206K Sell
317
-39
-11% -$27.1K 0.08% 326
2021
Q1 		$263K Buy
356
+6
+2% +$4.84K 0.11% 275
2020
Q4 		$270K Buy
350
+36
+11% +$28.4K 0.11% 275
2020
Q3 		$312K Sell
314
-43
-12% -$45.6K 0.16% 212
2020
Q2 		$371K Buy
357
+180
+102% +$181K 0.18% 234
2020
Q1 		$144K Sell
177
-26
-13% -$27.2K 0.06% 288
2019
Q4 		$254K Buy
203
+47
+30% +$75.7K 0.04% 288
2019
Q3 		$209K Sell
156
-9
-5% -$14.3K 0.04% 241
2019
Q2 		$292K Buy
+165
New +$253K 0.06% 226

Other funds holding GOSS

State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Virtus ETF Advisers's GOSS Position: Q4 2022 in Review

Virtus ETF Advisers sold out of Gossamer Bio (GOSS) in Q4 2022, closing a stake of 219 shares — an estimated $210K sold.

Virtus ETF Advisers first reported a position in GOSS in Q2 2019 and held it in 14 quarters. The position peaked at $371K in Q2 2020. 118 funds tracked by Wall St. Rank hold GOSS as of Q4 2022.

  • Virtus ETF Advisers reported no remaining Gossamer Bio position as of Q4 2022 after selling out during the quarter.
  • Virtus ETF Advisers sold 219 Gossamer Bio shares in Q4 2022, an estimated $210K.
  • Virtus ETF Advisers first reported a position in Gossamer Bio in Q2 2019 and held it in 14 quarters.
  • Virtus ETF Advisers's Gossamer Bio position peaked at $371K in Q2 2020.
  • 118 funds tracked by Wall St. Rank held Gossamer Bio as of Q4 2022.

Based on Virtus ETF Advisers's 13F filing for Q4 2022, filed 14 Feb 2023.